المؤلفون: Chrysoula Kosmeri, Maria Baltogianni, Vasileios Giapros, Ekaterini Siomou, Vasiliki-Regina Tsinopoulou, Foteini Balomenou, Anastasios Serbis

المصدر: Endocrines, Vol 5, Iss 2, Pp 214-224 (2024)

مصطلحات موضوعية: basal insulin, icodec, once-weekly analog, type 1 diabetes, Diseases of the endocrine glands. Clinical endocrinology, RC648-665

وصف الملف: electronic resource

العلاقة: https://www.mdpi.com/2673-396X/5/2/15Test; https://doaj.org/toc/2673-396XTest

الوصول الحر: https://doaj.org/article/0b91297f66ed48269b92474422e11b72Test

المؤلفون: Ibrahimu Mdala, Kjersti Nøkleby, Tore Julsrud Berg, John Cooper, Sverre Sandberg, Karianne Fjeld Løvaas, Tor Claudi, Anne Karen Jenum, Esben Selmer Buhl

المصدر: Scandinavian Journal of Primary Health Care, Vol 42, Iss 1, Pp 132-143 (2024)

مصطلحات موضوعية: Type 2 diabetes mellitus, general practice, primary care, therapeutic inertia, basal insulin, insulin initiation, Public aspects of medicine, RA1-1270

وصف الملف: electronic resource

العلاقة: https://doaj.org/toc/0281-3432Test; https://doaj.org/toc/1502-7724Test

الوصول الحر: https://doaj.org/article/ff64f50a3f634fe899c48b76cad39b2aTest

المؤلفون: Mohsen Dehghani, Masoumeh Sadeghi, Farzaneh Barzkar, Zohreh Maghsoomi, Leila Janani, Seyed Abbas Motevalian, Yoon K. Loke, Faramarz Ismail-Beigi, Hamid Reza Baradaran, Mohammad E. Khamseh

المصدر: Frontiers in Endocrinology, Vol 15 (2024)

مصطلحات موضوعية: basal insulin, blood glucose, body weight, diabetes treatment, hypoglycemia, network meta-analysis, Diseases of the endocrine glands. Clinical endocrinology, RC648-665

وصف الملف: electronic resource

العلاقة: https://www.frontiersin.org/articles/10.3389/fendo.2024.1286827/fullTest; https://doaj.org/toc/1664-2392Test

الوصول الحر: https://doaj.org/article/450df41ce24549ce99e3ecc42be8c7e7Test

المؤلفون: V.I. Katerenchuk, A.V. Katerenchuk

المصدر: Mìžnarodnij Endokrinologìčnij Žurnal, Vol 19, Iss 3, Pp 240-247 (2023)

مصطلحات موضوعية: insulin therapy, type 2 diabetes mellitus, basal insulin, fixed combination of basal insulin with a glucagon-like peptide-1 receptor agonist, Diseases of the endocrine glands. Clinical endocrinology, RC648-665

وصف الملف: electronic resource

العلاقة: https://iej.zaslavsky.com.ua/index.php/journal/article/view/1277Test; https://doaj.org/toc/2224-0721Test; https://doaj.org/toc/2307-1427Test

الوصول الحر: https://doaj.org/article/899a4319c1fb4fe4b231af571cd318afTest

المؤلفون: T. Yu. Demidova, V. V. Titova, Т. Ю. Демидова, В. В. Титова

المصدر: Meditsinskiy sovet = Medical Council; № 23 (2023); 209-216 ; Медицинский Совет; № 23 (2023); 209-216 ; 2658-5790 ; 2079-701X

مصطلحات موضوعية: инсулинотерапия, basal insulin, glycemic control, hypoglycemia, insulin analogues, insulin therapy, базальный инсулин, гликемический контроль, гипогликемия, аналоги инсулина

وصف الملف: application/pdf

العلاقة: https://www.med-sovet.pro/jour/article/view/8020/7112Test; Zang E, Lynch SM, West J. Regional differences in the impact of diabetes on population health in the USA. J Epidemiol Community Health. 2021;75(1):56–61. https://doi.org/10.1136/jech-2020-214267Test.; Magliano DJ, Boyko EJ; IDF Diabetes Atlas 10th edition scientific committee. IDF Diabetes Atlas. 10th ed. Brussels: International Diabetes Federation; 2021. Available at: https://www.ncbi.nlm.nih.gov/books/NBK581934Test.; GBD 2021 Diabetes Collaborators. Global, regional, and national burden of diabetes from 1990 to 2021, with projections of prevalence to 2050: a systematic analysis for the Global Burden of Disease Study 2021. Lancet. 2023;402(10397):203–234. https://doi.org/10.1016/S0140-6736Test(23)01301-6.; Дедов ИИ, Шестакова МВ, Викулова ОК, Железнякова АВ, Исаков МА, Сазонова ДВ, Мокрышева НГ. Сахарный диабет в Российской Федерации: динамика эпидемиологических показателей по данным Федерального регистра сахарного диабета за период 2010–2022 гг. Сахарный диабет. 2023;26(2):104–123. https://doi.org/10.14341/DM13035Test.; Демидова ТЮ, Титова ВВ. Инсулинотерапия – персонализированный подход к управлению гликемией при сахарном диабете. Терапевтический архив. 2020;92(12):201–206. https://doi.org/10.26442/00403660.2020.12.200449Test.; Дедов ИИ. Современные базальные инсулины: продолжение истории или начало новой эры? Сахарный диабет. 2015;18(4):5–11.https://doi.org/10.14341/DM7693Test.; Rosenstock J, Park G, Zimmerman J. Basal insulin glargine (HOE 901) versus NPH insulin in patients with type 1 diabetes on multiple daily insulin regimens. U.S. Insulin Glargine (HOE 901) Type 1 Diabetes Investigator Group. Diabetes Care. 2000;23(8):1137–1142. https://doi.org/10.2337/diacare.23.8.1137Test.; Дедов ИИ, Шестакова МВ, Майоров АЮ, Мокрышева НГ, Викулова ОК, Галстян ГР и др. Алгоритмы специализированной медицинской помощи больным сахарным диабетом. Сахарный диабет. 2021;24(Прил. 1):1–148. https://doi.org/10.14341/DM12802Test.; ElSayed NA, Aleppo G, Aroda VR, Bannuru RR, Brown, FM, Bruemmer D et al. 9. Pharmacologic Approaches to Glycemic Treatment: Standards of Care in Diabetes-2023. Diabetes Care. 2023;46(Suppl. 1):140–157. https://doi.org/10.2337/dc23-S009Test.; Davies MJ, Aroda VR, Collins B, Gabbay RA, Green J, Maruthur NM et al. Management of Hyperglycemia in Type 2 Diabetes, 2022. A Consensus Report by the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD). Diabetes Care. 2022;45(11):2753–2786. https://doi.org/10.2337/dci22-0034Test.; Kilpatrick ES, Rigby AS, Atkin SL. The effect of glucose variability on the risk of microvascular complications in type 1 diabetes. Diabetes Care. 2006;29(7):1486–1490. https://doi.org/10.2337/dc06-0293Test.; Lachin JM, Bebu I, Bergenstal RM, Pop-Busui R, Service FJ, Zinman B et al. Association of Glycemic Variability in Type 1 Diabetes With Progression of Microvascular Outcomes in the Diabetes Control and Complications Trial. Diabetes Care. 2017;40(6):777–783. https://doi.org/10.2337/dc16-2426Test.; Park JY, Hwang JH, Kang MJ, Sim HE, Kim JS, Ko KS. Effects of glycemic variability on the progression of diabetic retinopathy among patients with type 2 diabetes. Retina. 2021;41(7):1487–1495. https://doi.org/10.1097/IAE.0000000000003049Test.; Low S, Lim SC, Yeoh LY, Liu YL, Liu JJ, Fun S et al. Effect of long-term glycemic variability on estimated glomerular filtration rate decline among patients with type 2 diabetes mellitus: Insights from the Diabetic Nephropathy Cohort in Singapore. J Diabetes. 2017;9(10):908–919. https://doi.org/10.1111/1753-0407.12512Test.; Martinez M, Santamarina J, Pavesi A, Musso C, Umpierrez GE. Glycemic variability and cardiovascular disease in patients with type 2 diabetes. BMJ Open Diabetes Res Care. 2021;9(1):e002032. https://doi.org/10.1136/bmjdrc-2020-002032Test.; Ceriello A, Lucisano G, Prattichizzo F, La Grotta R, Franzén S, Svensson AM et al. HbA1c variability predicts cardiovascular complications in type 2 diabetes regardless of being at glycemic target. Cardiovasc Diabetol. 2022;21(1):13–21. https://doi.org/10.1186/s12933-022-01445-4Test.; Berard L, Antonishyn N, Arcudi K, Blunden S, Cheng A, Goldenberg R et al. Insulin Matters: A Practical Approach to Basal Insulin Management in Type 2 Diabetes. Diabetes Ther. 2018;9(2):501–519. https://doi.org/10.1007/s13300-018-0375-7Test.; Davies MJ, D’Alessio DA, Fradkin J, Kernan WN, Mathieu C, Mingrone G et al. Management of Hyperglycemia in Type 2 Diabetes, 2018. A Consensus Report by the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD). Diabetes Care. 2018;41(12):2669–2701. https://doi.org/10.2337/dci18-0033Test.; Hanefeld M, Fleischmann H, Siegmund T, Seufert J. Rationale for Timely Insulin Therapy in Type 2 Diabetes Within the Framework of Individualised Treatment: 2020 Update. Diabetes Ther. 2020;11(8):1645–1666. https://doi.org/10.1007/s13300-020-00855-5Test.; Генделека ГФ, Генделека АН. Инсулинотерапия сахарного диабета второго типа. Международный эндокринологический журнал. 2020;16(1):63–68. https://doi.org/10.22141/2224-0721.16.1.2020.199130Test.; Калягин АН, Максикова ТМ, Казакова РВ, Шистеева НП. Актуальные возможности фармакотерапии сахарного диабета 2 типа. Альманах сестринского дела. 2018;11(1):17–24. Режим доступа: https://www.ismu.baikal.ru/ismu/common.php?page_doc&doc=139239Test.; Mashitisho M, Mashitisho B. Early insulin therapy in patients with type 2 diabetes mellitus. J Endocrinol, Metab Diabetes South Africa. 2016;21(1):13–15. https://doi.org/10.1080/16089677.2016.1160539Test.; Polonsky WH, Arsenault J, Fisher L, Kushner P, Miller EM, Pearson TL et al. Initiating insulin: How to help people with type 2 diabetes start and continue insulin successfully. Int J Clin Pract. 2017;71(8):e12973. https://doi.org/10.1111/ijcp.12973Test.; Inotai A, Csanadi M, Petrova G, Dimitrova M, Bochenek T, Tesar T et al. Patient Access, Unmet Medical Need, Expected Benefits, and Concerns Related to the Utilisation of Biosimilars in Eastern European Countries: A Survey of Experts. Biomed Res Int. 2018;2018:9597362. https://doi.org/10.1155/2018/9597362Test.; Gough S. Biosimilar insulins: opportunities and challenges. Practical Diabetes. 2013;30(4):146–147a. https://doi.org/10.1002/pdi.1763Test.; Вербовой АФ, Долгих ЮА, Шаронова ЛА. Биосимиляры инсулинов в клинической практике. Медицинский совет. 2021;(21-1):131–138. https://doi.org/10.21518/2079-701X-2021-21-1-131-138Test.; Булгакова СВ, Саверская ЕН, Шаронова ЛА, Долгих ЮА, Косарева ОВ. Биосимиляр аналога инсулина гларгин: доказанная безопасность, эффективность, взаимозаменяемость. Медицинский совет. 2022;16(23):207–214. https://doi.org/10.21518/2079-701X-2022-16-23-207-214Test.; Майоров АЮ, Драй РВ, Каронова ТЛ, Авдеева ОИ, Макаренко ИЕ, Кокшарова ЕО и др. Оценка биоподобия препаратов РинГлар® (ООО «Герофарм», Россия) и Лантус® («Санофи-Авентис Дойчланд ГмбХ», Германия) с использованием метода эугликемического гиперинсулинемического клэмпа у пациентов с сахарным диабетом 1 типа: двой ное слепое рандомизированное клиническое исследование. Сахарный диабет. 2020;23(4):304–315. https://doi.org/10.14341/DM10095Test.; Karonova TL, Mosikian AA, Mayorov AY, Makarenko IE, Zyangirova ST, Afonkina OA et al. Safety and efficacy of GP40061 compared with originator insulin glargine (Lantus®): a randomized open-label clinical trial. J Comp Eff Res. 2020;9(4):263–273. https://doi.org/10.2217/cer-2019-0136Test.; Платонов ВВ, Дубинина ТА, Патракеева ЕМ, Резвых АМ, Казаченко НВ. Оценка эффективности применения отечественных биосимиляров инсулина для лечения сахарного диабета 1 типа у подростков. РМЖ. Мать и дитя. 2022;5(2):164–168. https://doi.org/10.32364/2618-84302022-5-2-165-168Test.; https://www.med-sovet.pro/jour/article/view/8020Test

الإتاحة: https://doi.org/10.21518/ms2023-439Test
https://doi.org/10.1136/jech-2020-214267Test
https://doi.org/10.1016/S0140-6736Test(23)01301-6
https://doi.org/10.14341/DM13035Test
https://doi.org/10.26442/00403660.2020.12.200449Test
https://doi.org/10.2337/diacare.23.8.1137Test
https://doi.org/10.14341/DM12802Test
https://doi.org/10.2337/dc23-S009Test
https://doi.org/10.2337/dci22-0034Test
https://doi.org/10.2337/dc06-0293Test

المؤلفون: Meir Schechter, Cheli Melzer Cohen, Alisa Fishkin, Aliza Rozenberg, Ilan Yanuv, Dvora R. Sehtman-Shachar, Gabriel Chodick, Alice Clark, Trine J. Abrahamsen, Jack Lawson, Avraham Karasik, Ofri Mosenzon

المصدر: Cardiovascular Diabetology, Vol 22, Iss 1, Pp 1-12 (2023)

مصطلحات موضوعية: GLP-1 RA, Basal insulin, Chronic kidney disease, Real world evidence, Type 2 diabetes, eGFR slope, Diseases of the circulatory (Cardiovascular) system, RC666-701

وصف الملف: electronic resource

العلاقة: https://doaj.org/toc/1475-2840Test

الوصول الحر: https://doaj.org/article/9521c0be51314f39acf728abf59b4868Test

المؤلفون: Ekberg, N. R., Hartvig, N. V., Kaas, A., Møller, J. B., Adolfsson, Peter, 1963

المصدر: Journal of Diabetes Science and Technology. 18(1):66-73

مصطلحات موضوعية: Endocrinology and Diabetes, Endokrinologi och diabetes, adherence, basal insulin, glycemic control, smart insulin pen, time in range, type 1 diabetes

الوصول الحر: https://gup.ub.gu.se/publication/321953Test

المؤلفون: Barbora Pavlikova, Martina Breburdova, Michal Krcma, Miroslav Kriz, Jan Kasparek, Zdenek Rusavy

المصدر: Life, Vol 14, Iss 5, p 568 (2024)

مصطلحات موضوعية: type 2 diabetes, therapy de-intensification, bolus-basal insulin therapy, glucagon-like peptide 1 analogues, liraglutide, fasting test, Science

وصف الملف: electronic resource

العلاقة: https://www.mdpi.com/2075-1729/14/5/568Test; https://doaj.org/toc/2075-1729Test

الوصول الحر: https://doaj.org/article/1f4c99154ddc41df8ddf7154f97b9126Test

المؤلفون: Christiano Argano, Laura Priola, Francesco Manno, Salvatore Corrao

المصدر: Biomedicines, Vol 12, Iss 4, p 900 (2024)

مصطلحات موضوعية: weekly insulin, icodec, LY3209590 basal insulin Fc (BIF), type 1 diabetes mellitus, type 2 diabetes mellitus, Biology (General), QH301-705.5

وصف الملف: electronic resource

العلاقة: https://www.mdpi.com/2227-9059/12/4/900Test; https://doaj.org/toc/2227-9059Test

الوصول الحر: https://doaj.org/article/f4d5646a352142478db42afde8663ca9Test

المؤلفون: V.I. Katerenchuk

المصدر: Mìžnarodnij Endokrinologìčnij Žurnal, Vol 19, Iss 1, Pp 72-78 (2023)

مصطلحات موضوعية: review, type 2 diabetes mellitus, insulin therapy, basal insulin, dose titrations algorithm, nph insulin, glargine, degludec, detemir, Diseases of the endocrine glands. Clinical endocrinology, RC648-665

وصف الملف: electronic resource

العلاقة: https://iej.zaslavsky.com.ua/index.php/journal/article/view/1244Test; https://doaj.org/toc/2224-0721Test; https://doaj.org/toc/2307-1427Test

الوصول الحر: https://doaj.org/article/eb1e7ba503154c40af230e98a0e17d74Test